Patents by Inventor Mariana Nacht

Mariana Nacht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132622
    Abstract: The present application relates to particular anti-PAD4 (peptidyl arginine deiminase 4) antibodies, nucleic acids encoding the antibodies, vectors and host cells comprising the nucleic acids, and methods of making and using the antibodies.
    Type: Application
    Filed: July 20, 2023
    Publication date: April 25, 2024
    Applicant: Bristol-Myers Squibb Company
    Inventors: Lin Hui Su, Ekaterina Deyanova, Burce Ergel Gurbuzbalaban, Mariana Nacht, Samantha Elaine Pace, Yun Wang, Qing Xiao, Ramakrishna Chandran, Shailesh Dudhgaonkar, Michael Louis Doyle, Michael Gilman, Richard Huang, Akbar Nayeem, Alok Sharma, Qihong Zhao
  • Publication number: 20210177781
    Abstract: Aspects of the disclosure relate to compositions, kits, and methods for the treatment of cancer that utilize a selective histonc deacetylase 3 (HDAC3) inhibitor. In some aspects, the compositions, kits, and methods relate to use of a selective HDAC3 inhibitor in combination with an immunotherapy agent (e.g., an immune checkpoint inhibitor).
    Type: Application
    Filed: January 11, 2019
    Publication date: June 17, 2021
    Inventors: Edward Holson, Mariana Nacht
  • Publication number: 20190216754
    Abstract: Aspects of the disclosure relate to compositions, kits, and methods for the treatment of cancer that utilize a selective histonc deacetylase 3 (HDAC3) inhibitor. In some aspects, the compositions, kits, and methods relate to use of a selective HDAC3 inhibitor in combination with an immunotherapy agent (e.g., an immune checkpoint inhibitor).
    Type: Application
    Filed: January 11, 2019
    Publication date: July 18, 2019
    Inventors: Edward Holson, Mariana Nacht
  • Patent number: 7709202
    Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: May 4, 2010
    Assignees: The Johns Hopkins University, Genzyne Corporation, The U.S.A. as represented by the Secretary of the HHS
    Inventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen L Madden, Jin Jen
  • Publication number: 20090270265
    Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.
    Type: Application
    Filed: July 27, 2007
    Publication date: October 29, 2009
    Applicants: The United States of America as Represented by the Secretary of Health and Human Services, Genzyme Corporation, The Johns Hopkins University School of Medicine
    Inventors: Mariana NACHT, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
  • Patent number: 7332590
    Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: February 19, 2008
    Assignees: The United States of America as Represented by the Department of Health and Human Services, Genzyme Corporation, The Johns Hopkins University of Medicine
    Inventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
  • Publication number: 20070224596
    Abstract: This invention provides compositions and methods to identify candidate agents capable of altering the biological activity of a polypeptide encoded by a polynucleotide involved in hypoxia-related tumorigenesis. In one aspect, the biological activity is the induction of hypoxia-related gene enolase 2 or a biological equivalent thereof. In another aspect, the biological activity is the induction of a hypoxia-related gene, inducible in the absence of the von Hippel-Lindau tumor suppressor (VHL). In yet a further aspect, the biological activity is differential expression in a neoplastic cell under hypoxia. In an alternative aspect, the biological activity is induction of a gene that is inducible in the absence of VHL, but not hypoxia.
    Type: Application
    Filed: January 20, 2006
    Publication date: September 27, 2007
    Inventors: Mariana Nacht, Yide Jiang
  • Publication number: 20050136403
    Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.
    Type: Application
    Filed: August 16, 2002
    Publication date: June 23, 2005
    Inventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
  • Publication number: 20030148939
    Abstract: This invention provides for methods of modulating angiogenesis and/or endothelial cell proliferation. In particular, applications of reducing or inhibiting angiogenesis, tumor growth, endothelial proliferation by the administration of compositions containing Claudin-7 and biological equivalents thereof. The invention also relates to compositions and methods for treatment for disorders associated with angiogeneis (e.g., cancer).
    Type: Application
    Filed: February 5, 2002
    Publication date: August 7, 2003
    Inventor: Mariana Nacht